ITEMS IN AFP WITH KEYWORD:
Apr 15, 2016 Issue
Screening for Breast Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends biennial screening mammography for women aged 50 to 74 years.
Practical strategies can help family physicians and women in their 40s make more informed decisions about breast cancer screening.
A woman presented with a rash that began as a large plaque affecting one-fourgh of her breast then decreased to a small plaque affecting only the nipple.
Jan 15, 2015 Issue
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends that primary care clinicians screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with one of several screening tools designed to identify a family history that may be associated with an increased risk of p...
Jan 15, 2015 Issue
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women [Putting Prevention into Practice]
L.M. is a 37-year-old nonsmoking woman who is not taking any medications and has no significant past medical problems. Three of her female relatives have a history of breast cancer: her mother (diagnosed at 49 years of age, before menopause), her paternal grandmother (diagnosed at 72 years of age), ...
Nov 1, 2014 Issue
Medications for Risk Reduction of Primary Breast Cancer in Women: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians engage in shared, informed decision making with women who are at increased risk of breast cancer about medications to reduce their risk. For women who are at increased risk of breast cancer and at low risk of adverse medicat...
Postmenopausal women at high risk of developing breast cancer who take anastrozole for five years have a lower rate of developing invasive breast cancer during that time frame.
In some postmenopausal women at higher-than-average risk of breast cancer, tamoxifen and, to a lesser extent, raloxifene (Evista) will prevent the development of breast cancer. For every 1,000 women who receive the prophylaxis, there will be seven to nine fewer cases of diagnosed breast cancer. Canc...
Implementation of a universal mammographic screening program leads to an increase in the diagnosis of invasive breast cancer, because of improved detection of clinically significant cancer and overdiagnosis.
Screening mammography is one of an increasing number of clinical issues that will require rethinking the clinical mission and restructuring clinical practice to help patients make informed choices.